This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Dividendos de Oak Street Health

Dividendo controles de criterios 0/6

Información clave

n/a

Rentabilidad por dividendo

n/a

Ratio de pago

Rentabilidad media de la industria	1.6%
Próxima fecha de pago de dividendos	n/a
Fecha ex dividendo	n/a
Dividendo por acción	n/a
Beneficios por acción	-US$2.08
Rentabilidad por dividendo prevista a 3 años	0%

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

Oak Street Health, Inc. (NYSE:OSH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Jan 28

Oak Street Health Grows Revenue But Struggles With Higher Medical Costs

Dec 22

Oak Street Health: Poised For Growth Following RubiconMD Deal

Dec 01

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Insufficient data to determine if OSH's dividends per share have been stable in the past.

Dividendo creciente: Insufficient data to determine if OSH's dividend payments have been increasing.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Oak Street Health vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de OSH con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (OSH)	n/a
Suelo de mercado 25% (US)	1.5%
Techo de mercado 25% (US)	4.6%
Media de la industria (Healthcare)	1.6%
Previsión de analistas en 3 años (OSH)	0%

Dividendo destacado: Unable to evaluate OSH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Alto dividendo: Unable to evaluate OSH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Pago de beneficios a los accionistas

Cobertura de los beneficios: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: Unable to calculate sustainability of dividends as OSH has not reported any payouts.

This company has been acquired

Dividendos de Oak Street Health

Dividendo controles de criterios 0/6

Información clave

Últimas actualizaciones de dividendos

Recent updates

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Financial Officer recently sold US$232k worth of stock

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Innovation Officer & Director recently sold US$274k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Innovation Officer & Director notifies of intention to sell stock

CVS Health Corporation (NYSE:CVS) entered into a definitive agreement to acquire Oak Street Health, Inc. (NYSE:OSH) from Newlight Partners LP, General Atlantic LLC and others for $9.6 billion.

Price target increased by 8.5% to US$35.00

CVS Health Corporation (NYSE:CVS) entered into a definitive agreement to acquire Oak Street Health, Inc. (NYSE:OSH) from Newlight Partners LP, General Atlantic LLC and others for $9.6 billion.

CVS close to acquiring Oak Street Health for $10.5B - WSJ

Chief Legal Officer & Secretary notifies of intention to sell stock

Chief Innovation Officer & Director notifies of intention to sell stock

CVS Reportedly Explores an Acquisition of Oak Street Health

Oak Street Health jumps on report of CVS takeover interest

Chief Operating Officer notifies of intention to sell stock

Oak Street Health, Inc. Appoints Deb Edberg as First Chief Wellness Officer

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Operating Officer notifies of intention to sell stock

Oak Street Health, Inc. announced that it has received funding

Oak Street Health pares gain on report about takeover chances

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Oak Street Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2022

Oak Street Health Q3 2022 Earnings Preview

Chief Operating Officer notifies of intention to sell stock

Oak Street Health, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Chief Operating Officer notifies of intention to sell stock

Board Member notifies of intention to sell stock

Oak Street Health Launches Nurse Practitioner Fellowship in Adult Primary Care

Oak Street Health downgraded at Goldman Sachs citing cloudy outlook

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Operating Officer recently sold US$258k worth of stock

Oak Street Health, Inc. has completed a Follow-on Equity Offering in the amount of $180.25 million.

Oak Street Health, Inc. has completed a Follow-on Equity Offering in the amount of $180.25 million.

Oak Street Health slips aftermarket on secondary stock offering

Consensus forecasts updated

CEO & Chairman notifies of intention to sell stock

Price target increased to US$31.78

Second quarter 2022 earnings: EPS misses analyst expectations

Oak Street Health, Inc. Provides Earnings Guidance for the Three Months Ending September 30, 2022 and Twelve Months Ending December 31, 2022

Oak Street Health Q2 2022 Earnings Preview

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Innovation Officer & Director notifies of intention to sell stock

Oak Street Health, Inc. to Report Q2, 2022 Results on Aug 02, 2022

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Innovation Officer & Director notifies of intention to sell stock

Oak Street Health, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2022 and for the Full Year Ending December 31, 2022

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Chief Innovation Officer & Director notifies of intention to sell stock

Chief Innovation Officer & Director notifies of intention to sell stock

Oak Street Health, Inc. to Report Q1, 2022 Results on May 03, 2022

Chief Innovation Officer & Director notifies of intention to sell stock

Full year 2021 earnings: EPS exceeds analyst expectations

Jakubowitz Law Commences Securities Fraud Class Action Lawsuit on Behalf of Shareholders of Oak Street Health, Inc

Oak Street Health, Inc. to Report Q4, 2021 Results on Feb 28, 2022

Oak Street Health, Inc. (NYSE:OSH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Price target decreased to US$46.00

Chief Innovation Officer & Director notifies of intention to sell stock

Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Oak Street Health, Inc

Price target decreased to US$50.38

President notifies of intention to sell stock

Chief Innovation Officer & Director notifies of intention to sell stock

Oak Street Health Grows Revenue But Struggles With Higher Medical Costs

COO & Director exercised options to buy US$161k worth of stock.

Chief Legal Officer & Secretary exercised options and sold US$210k worth of stock

Oak Street Health: Poised For Growth Following RubiconMD Deal

Chairman & CEO notifies of intention to sell stock

Chairman & CEO notifies of intention to sell stock

Third quarter 2021 earnings released: US$0.49 loss per share (vs US$0.15 loss in 3Q 2020)

Chairman & CEO notifies of intention to sell stock